(3633)野村全球生技醫療基金
依持有類股(資料日期:2025/10/17)
依產業(資料日期:2025/09/30)
依區域(資料日期:2025/09/30)
持股明細(資料日期:2025/09/30)
持股名稱比例
ALNYLAM PHARMACEUTICALS INC7.46%
GILEAD SCIENCES INC7.22%
VERTEX PHARMACEUTICALS INC6.64%
ELI LILLY & CO6.27%
AMGEN INC6.25%
ABBVIE INC5.42%
NEUROCRINE BIOSCIENCES INC5.32%
Astrazeneca Plc4.94%
LONZA GROUP AG-REG4.30%
BOSTON SCIENTIFIC4.27%
SPDR標普生技ETF3.75%
ARGENX SE - ADR3.51%
INCYTE CORP3.20%
Mckesson Corp2.92%
ROCHE HOLDING AG-GENUSSCHEIN2.26%
DAIICHI SANKYO CO LTD2.15%
HANSOH PHARMACEUTICAL GROUP1.92%
REGENERON PHARMACEUTICALS1.80%
ROYALTY PHARMA PLC- CL A1.79%
NOVARTIS AG-REG1.59%
iShares生技ETF1.57%
ECKERT & ZIEGLER SE1.48%
BIOGEN INC1.48%
AMNEAL PHARMACEUTICALS INC1.21%
DOXIMITY INC-CLASS A1.18%
中裕1.16%
LENZ THERAPEUTICS INC1.12%
JIANGSU HENGRUI PHARMACEUTIC1.06%
INTUITIVE SURGICAL1.03%
INNOVENT BIOLOGICS INC1.00%
投資注意事項